Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and ...
Introduction Diabetic macular edema (DME) is a major cause of vision impairment in patients with diabetic retinopathy (DR).1 The current standard of care for DME treatment includes short-acting intravitreal injections of anti-vascular endothelial growth …